$18.17
1.267.45%
Ult. Agg.: Nov 9, 7:59 PM
The average analyst price target for Tandem Diabetes Care is $27.90, 68.1% above the current price. Of 20 analysts, 11 rate it Buy and 9 Hold. Targets range from $12 to $60. The latest change came on Nov 6, 2026, when Barclays raised its price target on Tandem Diabetes Care from $18 to $20 and kept an Equal-Weight rating.
Price Target Range — 11 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months